Ocular Therapeutix Competitors and Similar CompaniesClear all

Ocular Therapeutix's competitors and similar companies include Mati Therapeutics, Opthea and CSL Behring.

	Ocular Therapeutix Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.	Mati Therapeutics Mati Therapeutics is a company that develops a non-invasive sustained drug delivery platform.	Opthea Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.	CSL Behring CSL Behring is a provider of life-saving medicines.
Founding Date	Founding Date 2006	Founding Date 2012	Founding Date 2012	Founding Date 1904
Type	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare medical devices therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development pharma
Locations	Locations Bedford, US HQ Bedford, US Bedford, US	Locations Austin, US HQ Burnaby, CA	Locations South Yarra, AU HQ Toorak, AU	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more
Employees	Employees 16740% increase	Employees N/A	Employees 33	Employees 7,5692% decrease
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) N/A	Valuation ($) 711.2 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $52m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $25k (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)
Cost of goods	Cost of goods $6.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $45.4m (FY, 2025)	Gross profit N/A	Gross profit $146k (FY, 2025)	Gross profit $4.5b (FY, 2020)
Net income	Net income ($265.9m) (FY, 2025)	Net income N/A	Net income ($162.8m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 73.3m	Total funding raised $ 1.6m	Total funding raised $ 67.6m	Total funding raised N/A